InvOpps GP IV, L.L.C., Director, 10% Owner at Oyster Point Pharma, Inc. (OYST), bought 1,980,050 shares at $16.00 ($12.0M) on 2019-11-04, disclosed to the SEC on 2019-11-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,230,050 | $0 | 0.0% |
| 2 | $16.00 | 248,625 | $4.0M | 33.1% |
| 3 | $16.00 | 501,375 | $8.0M | 66.8% |
| Total | $6.06 avg | 1,980,050 | $12.0M | 100% |